Overall, our data indicate that a MtlD inhibitor coupled with mannitol may be an effective therapeutic strategy in combating gastroenteritis or systemic infection caused by the nontyphoidal Salmonella serovars including the invasive nontyphoidal serovars that have recently emerged in Africa. Here, BMP1 is linked to gastroenteritis.